2011
DOI: 10.1016/j.tim.2011.07.004
|View full text |Cite
|
Sign up to set email alerts
|

Importance of Candida–bacterial polymicrobial biofilms in disease

Abstract: Candida albicans is the most prevalent human fungal pathogen, with an ability to inhabit diverse host niches and cause disease in both immunocompetent and immunocompromised individuals. C. albicans also readily forms biofilms on indwelling medical devices and mucosal tissues, which serve as an infectious reservoir that is difficult to eradicate, and can lead to lethal systemic infections. Biofilm formation occurs within a complex milieu of host factors and other members of the human microbiota. Polymicrobial i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

5
245
1
2

Year Published

2014
2014
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 277 publications
(253 citation statements)
references
References 91 publications
5
245
1
2
Order By: Relevance
“…However, an important line of defence against oral CMC is the oral microbiota that prevents infections by their interplay with immune cells, nutrients, metabolic products and by secreting antagonistic molecules, which together balance local inflammatory responses [39]. C. albicans can form biofilms with many oral bacteria, including streptococci [40], which have synergistic or antagonistic influences on C. albicans . Noteworthy, recent work has highlighted the critical role of metabolic products from specific gut microbiota such as lactobacilli in priming IL-22 dependent mucosal immune responses by innate lymphoid cells via the aryl hydrocarbon receptor, which is fundamental for protection against uncontrolled local Candida expansion [41].…”
Section: Discussionmentioning
confidence: 99%
“…However, an important line of defence against oral CMC is the oral microbiota that prevents infections by their interplay with immune cells, nutrients, metabolic products and by secreting antagonistic molecules, which together balance local inflammatory responses [39]. C. albicans can form biofilms with many oral bacteria, including streptococci [40], which have synergistic or antagonistic influences on C. albicans . Noteworthy, recent work has highlighted the critical role of metabolic products from specific gut microbiota such as lactobacilli in priming IL-22 dependent mucosal immune responses by innate lymphoid cells via the aryl hydrocarbon receptor, which is fundamental for protection against uncontrolled local Candida expansion [41].…”
Section: Discussionmentioning
confidence: 99%
“…It has been estimated that 80% of human infections result from pathogenic biofilms (Harriott and Noverr, 2011). Clinically, biofilm infections represent an overwhelming problem, as the microorganisms embedded in the extracellular matrix are resistant to antibiotics as well as to the host defence.…”
Section: Introductionmentioning
confidence: 99%
“…This species can cause infections that range from superficial lesions of the mucosa or skin to severe systemic infections. 1,2 C. albicans shows a great capacity of biofilm formation on oral structures and its presence in the oral cavity may serve as a reservoir of this fungus for infections in other parts of the body. 3 Current treatment for candidiasis consists of the administration of topical antifungal agents such as nystatin, amphotericin B and clotrimazole, or systemic antifungal agents such as fluconazole, ketoconazole and itraconazole.…”
Section: Introductionmentioning
confidence: 99%